Review
doi: 10.1007/978-1-4614-2364-5_6.
RAMPs as drug targets
Affiliations
- PMID: 22434108
- DOI: 10.1007/978-1-4614-2364-5_6
Item in Clipboard
Review
RAMPs as drug targets
Adv Exp Med Biol.
2012.
Abstract
The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.